Atjaunināt sīkdatņu piekrišanu

Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities [Mīkstie vāki]

  • Formāts: Paperback / softback, 72 pages, height x width: 229x152 mm
  • Izdošanas datums: 22-Feb-2014
  • Izdevniecība: National Academies Press
  • ISBN-10: 0309297796
  • ISBN-13: 9780309297790
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 45,61 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 72 pages, height x width: 229x152 mm
  • Izdošanas datums: 22-Feb-2014
  • Izdevniecība: National Academies Press
  • ISBN-10: 0309297796
  • ISBN-13: 9780309297790
Citas grāmatas par šo tēmu:
Sharing data generated through the conduct of clinical trials offers the promise of placing evidence about the safety and efficacy of therapies and clinical interventions on a firmer basis and enhancing the benefits of clinical trials. Ultimately, such data sharing - if carried out appropriately - could lead to improved clinical care and greater public trust in clinical research and health care.



Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities is part of a study of how data from clinical trials might best be shared. This document is designed as a framework for discussion and public comment. This framework is being released to stimulate reactions and comments from stakeholders and the public. The framework summarizes the committee's initial thoughts on guiding principles that underpin responsible sharing of clinical trial data, defines key elements of clinical trial data and data sharing, and describes a selected set of clinical trial data sharing activities.

Table of Contents



Front Matter Discussion Framework for Clinical Trial Data Sharing References Appendix A: Statement of Task Appendix B: Committee Biographies Appendix C: Figure 1: Data Flow from Participant to Analyzed Data and Reporting
Context Of The Study
1(4)
Charge to the Committee and Scope of the Study
3(2)
A Framework For Discussion And Call For Comments
5(3)
Invitation For Public Comments
7(1)
Guiding Principles For Responsible Sharing Of Clinical Trial Data
8(9)
Respect the Individual Participants Whose Data Are Shared
9(1)
Respect Through Research Participant Protections
9(1)
Respect Through Engagement
10(1)
Maximize Benefits to Participants in Clinical Trials and to Society, While Minimizing Harm
10(4)
Potential Benefits
11(2)
Potential Harms
13(1)
Increase Public Trust in Clinical Trials
14(1)
Trust in Clinical Trial Data
14(1)
Trust in the Data Sharing Process
15(1)
Carry Out Sharing of Clinical Trial Data in a Manner That Enhances Fairness
15(2)
Fairness in Exposure to Potential Risks of Data Sharing
16(1)
Fairness in the Distribution of the Potential Benefits of Research
16(1)
Additional Observations Relating To Principles For Data Sharing
17(2)
Operational Strategies Following from Guiding Principles
17(1)
Framing Rights and Responsibilities: To Whom Do the Benefits of Clinical Trial Data Belong?
18(1)
Data Sharing Elements And Activities
19(18)
What Types of Data Could Be Shared?
20(7)
Current Practices in Data Disclosure
20(1)
Data
21(2)
Reports Generated from Data
23(2)
Metadata and Additional Documentation
25(2)
Who Are the Providers of Shared Data?
27(1)
Who Are the Recipients of Shared Data?
28(1)
When Might Clinical Trial Data Be Shared?
29(1)
How Might Data Be Shared?
29(5)
Open Access
33(1)
Controlled Access
33(1)
Selected Set of Clinical Trial Data Sharing Activities
34(3)
REFERENCES
37(6)
APPENDIXES
A Statement of Task
43(2)
B Committee Biographies
45(12)
C Figure 1: Data Flow from Participant to Analyzed Data and Reporting
57